Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 06 2019
Historique:
received: 13 12 2018
accepted: 21 05 2019
entrez: 5 6 2019
pubmed: 5 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

The human epidermal growth factor receptor 2 (HER2) gene amplification status is a crucial marker for evaluating clinical therapies of breast or gastric cancer. We propose a deep learning-based pipeline for the detection, localization and classification of interphase nuclei depending on their HER2 gene amplification state in Fluorescence in situ hybridization (FISH) images. Our pipeline combines two RetinaNet-based object localization networks which are trained (1) to detect and classify interphase nuclei into distinct classes normal, low-grade and high-grade and (2) to detect and classify FISH signals into distinct classes HER2 or centromere of chromosome 17 (CEN17). By independently classifying each nucleus twice, the two-step pipeline provides both robustness and interpretability for the automated detection of the HER2 amplification status. The accuracy of our deep learning-based pipeline is on par with that of three pathologists and a set of 57 validation images containing several hundreds of nuclei are accurately classified. The automatic pipeline is a first step towards assisting pathologists in evaluating the HER2 status of tumors using FISH images, for analyzing FISH images in retrospective studies, and for optimizing the documentation of each tumor sample by automatically annotating and reporting of the HER2 gene amplification specificities.

Identifiants

pubmed: 31160649
doi: 10.1038/s41598-019-44643-z
pii: 10.1038/s41598-019-44643-z
pmc: PMC6546913
doi:

Substances chimiques

ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8231

Références

BMC Clin Pathol. 2013 Apr 20;13:13
pubmed: 23601823
Oncologist. 1998;3(4):237-252
pubmed: 10388110
Science. 1987 Jan 9;235(4785):177-82
pubmed: 3798106
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
APMIS. 2014 Sep;122(9):755-60
pubmed: 24372629
IEEE Trans Pattern Anal Mach Intell. 2020 Feb;42(2):318-327
pubmed: 30040631
PLoS One. 2015 Apr 06;10(4):e0123201
pubmed: 25844540
Science. 1989 May 12;244(4905):707-12
pubmed: 2470152
J Natl Cancer Inst. 2001 Aug 1;93(15):1141-6
pubmed: 11481385
Adv Anat Pathol. 2011 Jan;18(1):53-9
pubmed: 21169738
Cold Spring Harb Symp Quant Biol. 2017;82:57-70
pubmed: 29183987
J Clin Oncol. 2005 Jul 1;23(19):4265-74
pubmed: 15911866
Cytometry A. 2018 Jun;93(6):620-627
pubmed: 29710381
Arch Pathol Lab Med. 2011 Jan;135(1):55-62
pubmed: 21204711
J Clin Oncol. 2007 Jan 1;25(1):118-45
pubmed: 17159189
Arch Pathol Lab Med. 2007;131(1):18-43
pubmed: 19548375
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
Br J Cancer. 2007 Feb 26;96(4):654-9
pubmed: 17262082
N Engl J Med. 2005 Oct 20;353(16):1673-84
pubmed: 16236738
Virchows Arch. 2010 Sep;457(3):299-307
pubmed: 20665045
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Falk Zakrzewski (F)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany. falk.zakrzewski@uniklinikum-dresden.de.

Walter de Back (W)

Institute for Medical Informatics and Biometry (IMB), Carl Gustav Carus Faculty of Medicine, TU Dresden, Dresden, Germany.
Center for Information Services and High Performance Computing (ZIH), TU Dresden, Dresden, Germany.

Martin Weigert (M)

Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany.
Center for Systems Biology Dresden (CSBD), Dresden, Germany.

Torsten Wenke (T)

ASGEN GmbH & Co. KG, Dresden, Germany.

Silke Zeugner (S)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.

Robert Mantey (R)

National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Christian Sperling (C)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.

Katrin Friedrich (K)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.

Ingo Roeder (I)

Institute for Medical Informatics and Biometry (IMB), Carl Gustav Carus Faculty of Medicine, TU Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Daniela Aust (D)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Gustavo Baretton (G)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Pia Hönscheid (P)

Institute of Pathology, University Hospital Carl Gustav Carus (UKD), TU Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH